Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-11

Clinical Trial Update: Safety and Immunogenicity Study of the Venezuelan Equine Encephalomyelitis Vaccine [Phase 2]

View source ↗

Summary

Phase 2 safety and immunogenicity update for the Venezuelan equine encephalomyelitis vaccine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Venezuelan equine encephalomyelitis vaccine (VEE vaccine)

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Venezuelan Equine Encephalomyelitis | Phase 2 | Status: UNKNOWN